In the recently published, ‘The Digital Pharmacies Era: How 3D Printing Technology Using Fused Deposition Modeling Can Become a Reality,’ Brazilian researchers further examine the potential of new technology for the pharmaceutical industry.
Digital fabrication has the obvious ability to transform many industries today, but the medical realm and other interconnected industries are already well on their way to participating in a highly beneficial technological revolution. Here, the researchers explore the use of FDM 3D printing to extrude drug-loaded filament.
Obviously, 3D printing offers a host of benefits for drug manufacturing. Like medicine itself, the ability to offer patient-specific treatment is monumental, including the fabrication of:
- Flexible dosages
- Different shapes
- Multiple active pharmaceutical ingredients
- Modulated release kinetics
“Moreover, the most diversified and sophisticated drug delivery devices for oral, dermal, and implantable administration can be produced with high accuracy using 3D printers,” stated the researchers.
Still, the industry is heavily entrenched in traditional methods of producing medications, and the researchers raise the question of whether or not FDM 3D printing is optimal for ‘largescale production.’
When a tablet machine is still 60 times faster, it is obvious 3D printing technology has a long way to go before becoming an accepted replacement.
“3D printers cannot match the velocity of industrial tablet machines, but they certainly serve to address an existing therapeutic gap with regard to the need for individualization of drug therapy, acting in a complementary or alternative manner to the conventional drug product production,” stated the researchers.
Another one of the advantages of 3D printing is its ability to offer quality, on-demand, small batch manufacturing—which may offer a more realistic approach for small-scale production at pharmacies.
While 3D printed medications such as epilepsy drug Spritam hit the market with quite a splash, there are still of course number regulatory and safety issues to be considered, and there would need to be many customizations made to 3D printers overall; however, the hardware is now both affordable and accessible. Currently, there is no model ready for pharmaceutical use, and parts would all need to be easily sterilized. Nozzles and software would need to be redesigned too.
Drug-loaded filaments would need to be created through:
- Mixing of the components for each batch.
- Hot-melt extruder produces filaments via shearing and heating.
- Filament then must be packed into spools, with pharmaceuticals sealed hermetically to avoid any breakdown or contamination.
Drug delivery would depend on medical technicians setting parameters, along with printer and spool preparation. Proper packaging of the product is critical too. And while the process is most important, without cooperation in figuring out what is needed from regulatory and patent agencies, the path to success would be nearly impossible.
“Research groups over the world are currently working to identify the nuances of the production process, and despite the great progress made so far, palpable planning to bring these products to life is necessary,” conclude the researchers.
“The potential of 3D printing for the development of personalized drug products is undeniable; however, machine adaptations are fundamental for proper pharmaceutical use. In addition, a viable production process needs the co-participation of the pharmaceutical industry (to extrude filaments on a large scale), and digital pharmacies (to print drugs according to patient-specific prescriptions).”
There is no doubt that 3D printing will be playing a huge role in the pharmaceutical industry, and the impacts are just beginning, leaving researchers to examine the challenges, study the benefits of patient-specific care, and examine benefits such as affordability.
What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.[Source / Images: ‘The Digital Pharmacies Era: How 3D Printing Technology Using Fused Deposition Modeling Can Become a Reality’]
You May Also Like
3D Printing News Briefs, January 12, 2022: Rebranding, Bioprinting, & More
First up in today’s 3D Printing News Briefs, Particle3D has gone through a rebrand, and a team of researchers developed a way to 3D print and preserve tissues in below-freezing...
3D Printing News Briefs, December 18, 2021: Business, Research, & A Metal Benchy
We’ve got business to share in today’s 3D Printing News Briefs, as Freemelt and Etteplan have entered into a strategic partnership, EOS installed its 1,000th 3D printer in the North...
Incus Closes Series A Round for Slurry SLA Metal 3D Printing
Austrian slurry stereolithography (SLA) company Incus has closed a series A round with AM Ventures and is bringing aboard ex-EOS CEO Adrian Keppler as a consultant, as well as investor....
BICO Announces Million-Dollar Contract for 3D Printed Joint Implants
For five years, Nanochon has been developing a 3D printed implantable device and novel nanomaterial to treat cartilage loss and damage in joints as an alternative to knee replacements. Now,...
View our broad assortment of in house and third party products.